Dapoxetine: Clinical Use, Pharmacology, and Legal Access for Research & Pharmaceutical Supply
Introduction
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation (PE) in men. Unlike traditional antidepressant SSRIs, Dapoxetine was engineered for rapid absorption and short elimination half-life, allowing on-demand use.
1. Informational Section: What Is Dapoxetine?
Dapoxetine hydrochloride is the first oral medication approved in several countries specifically for premature ejaculation. Its unique pharmacokinetic profile differentiates it from conventional SSRIs, offering rapid onset (within 1–2 hours) and short duration of action (~12 hours).
Table 1 – Chemical Properties of Dapoxetine
| Property |
Detail |
| Chemical Name |
(S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride |
| CAS Number |
129938-20-1 |
| Molecular Formula |
C21H23NO · HCl |
| Molecular Weight |
341.88 g/mol |
| Appearance |
White to off-white crystalline powder |
| Solubility |
Freely soluble in water and ethanol |
| Melting Point |
180 – 184 °C (HCl salt) |
| Storage Conditions |
Store at 2–8 °C in a dry, sealed container away from light |
| Therapeutic Class |
Short-acting SSRI |
| Dosage Forms (Approved) |
30 mg and 60 mg tablets |
| Common Brand Names |
Priligy®, Westoxetin®, Duratia® |
2. Pharmacological Profile and Mechanism of Action
Dapoxetine functions as a selective serotonin reuptake inhibitor, increasing serotonin levels in the synaptic cleft. This modulation delays ejaculation latency through serotonin receptor pathways, particularly 5-HT1A and 5-HT2C.
Pharmacokinetics Summary
- Absorption: Rapid, with peak plasma concentration within 1–2 hours after ingestion.
- Distribution: Extensively protein-bound (~99%).
- Metabolism: Hepatic metabolism primarily via CYP2D6, CYP3A4, and CYP2C19.
- Elimination Half-life: ~1.5 hours (shorter than typical SSRIs).
Clinical studies confirm that Dapoxetine can increase intravaginal ejaculatory latency time (IELT) by up to threefold compared with placebo.
3. Navigational Section: Research and Clinical Applications
3.1 Medical Use
Dapoxetine is approved in numerous regions (EU, Canada, parts of Asia) for the on-demand treatment of PE in men aged 18 – 64 years. It is typically administered 1–3 hours before sexual activity.
3.2 Research Use
Pharmaceutical R&D laboratories investigate Dapoxetine for:
- Comparative SSRI pharmacokinetics,
- Neurotransmitter receptor binding studies,
- Formulation optimization (controlled-release and sublingual systems),
- Pharmacogenomic analyses of CYP2D6 variability.
Navigating regulatory frameworks for Dapoxetine research requires Good Clinical Practice (GCP) and pharmacovigilance compliance.
4. Commercial Section: Pharmaceutical Manufacturing and Market Context
Global demand for Dapoxetine has expanded in line with rising awareness of sexual health and wellness therapeutics.
In the pharmaceutical ingredient market, Dapoxetine hydrochloride is distributed under strict GMP conditions.
Key Commercial Insights
- API Purity Standards: ? 99 % (HPLC)
- Stability: Excellent under normal pharmaceutical storage conditions
- Packaging: Sealed aluminum foil or HDPE drums for industrial-scale supply
- Certifications: cGMP, ISO 9001, and DMF-listed where applicable
Pharmaceutical buyers and contract manufacturers source Dapoxetine from audited suppliers with complete quality dossiers and COA/MSDS documentation.
5. Transactional Section: Legal and Compliant Procurement
To remain compliant, all purchases must adhere to national drug-control and pharmaceutical licensing frameworks.
Legal Supply Pathway
- Identify Authorized Manufacturers or Distributors
- Registered under national FDA, EMA, or equivalent agencies.
- Maintain valid Active Pharmaceutical Ingredient (API) registration.
- Request Technical Documents
- Certificate of Analysis (COA)
- Material Safety Data Sheet (MSDS)
- GMP compliance certificate
- File Import/Use Documentation
- Declaration of intended pharmaceutical or research use
- Institutional or corporate license details
- Secure Storage and Record-Keeping
- Follow ICH Q7 and WHO TRS 957 guidelines for API handling.
Regulatory Status Overview
| Region |
Status |
| European Union |
Approved under centralized and national marketing authorizations |
| United States |
Not FDA-approved (under review for specific formulations) |
| Canada |
Prescription-only medication |
| India |
Approved as prescription medicine (Schedule H) |
| Australia |
Schedule 4 (Prescription-Only) |
6. Safety, Tolerability, and Risk Profile
Dapoxetine is generally well tolerated, with dose-dependent side effects typical of SSRIs: nausea, headache, dizziness, and mild insomnia.
Contraindications include concurrent MAOI or thioridazine use.
Safety Recommendations
- Begin with 30 mg, assess tolerance before dose escalation.
- Avoid combining with alcohol or recreational substances.
- Conduct CYP2D6 pharmacogenetic screening for personalized therapy.
7. SEO and Industry Search Insights
Top search trends (2024 – 2025):
- “What is Dapoxetine used for?”
- “Dapoxetine mechanism of action”
- “Buy Dapoxetine API legally”
- “Dapoxetine vs. Sertraline comparison”
- “How Dapoxetine works for premature ejaculation”
Targeting these terms within compliant medical and pharmaceutical contexts increases organic visibility for B2B pharma buyers, clinicians, and researchers.
8. Conclusion
Dapoxetine represents a pharmacological innovation within short-acting SSRIs, offering effective, on-demand management of premature ejaculation. Its rapid action, short half-life, and favorable safety profile make it valuable to clinicians and pharmaceutical developers alike.
When sourced through licensed pharmaceutical channels and handled under GMP-compliant protocols, Dapoxetine serves as a benchmark for modern, targeted sexual-health therapeutics and advanced SSRI research.
Dapoxetine near me
